Cytodyn Inc (CYDY)

[tikotiko]

I agree. There is no doubt that the outstanding 82% efficacy by day 14 would have translated into similar numbers by day 28 with weekly doses. Unfortunately, that did not happen because of the reasons you presented and the many FDA’s games. This should be evident to any person with basic common sense and logic. Big Pharma companies are even more aware of this fact and of the possible extrapolations with weekly doses. I am convinced that they are watching closely. Nader should consider doing the US COVID trial with a BP partner to either split profits or consider a buyout. This could be somewhat similar to what RLFTF was planning to do with Redemsideath. At the same time, the international efforts should continue. The opportunity is now, but I am not sure if Nader’s stubbornness may get in the way. Regardless, I am holding long, because I know this therapeutic is better than anything else in the market, including the HGEN drug, which I also happen to own. The Leronlimab molecule is way too valuable and the big fish know it.